Plasma choline,smoking,and long-term prognosis in patients with stable angina pectoris

Abstract

Background

Plasma choline has been associated with cardiovascular disease and nonalcoholic steatohepatitis.

Design

We sought to study relations of plasma choline and its metabolite betaine to long-term risk of acute myocardial infarction (AMI) and all-cause mortality according to smoking status, in patients undergoing coronary angiography for stable angina pectoris.

Methods

Samples were obtained before angiography from 2568 patients who were subsequently randomized in the Western Norway B-Vitamin Intervention Trial (WENBIT). Hazard ratios (HR) were calculated using multivariate Cox-regression and p-values were reported for trends over quartiles.

Results

Plasma concentrations of choline, but not betaine, were lower in smokers, and choline was positively associated with C-reactive protein and troponin T in nonsmokers, but not in smokers (p for interaction <0.03). During a follow up of 4.8 ± 1.4 (mean ± SD) years, 8.3% suffered from AMI and 6.1% died. In the total population, choline was not associated with AMI or all-cause mortality. However, comparing the highest vs. the lowest quartiles, plasma choline was associated with increased risk of AMI in nonsmokers (HR 2.63, 95% CI 1.56 to 5.51; p for trend = 0.013) and no risk in smokers (p for interaction < 0.001). Plasma choline significantly improved discrimination and reclassification when added to established cardiovascular risk factors. Plasma betaine was not associated with either endpoint.

Conclusions

In patients with stable angina pectoris, elevated plasma choline is associated with elevated troponin levels and increased risk of AMI in nonsmokers. These results motivate further research into the relation between choline metabolism, smoking, and atherothrombosis.

Keywords

Betaine biomarker choline long-term prognosis smoking stable angina pectoris

Get full access to this article

View all access options for this article.

References

Vance

. Phosphatidylcholine and choline homeostasis. J Lipid Res 2008; 49: 1187–1194.

Zeisel

da Costa

. Choline: an essential nutrient for public health. Nutr Rev 2009; 67: 615–623.

Lin

. Choline oxidation and choline dehydrogenase. J Protein Chem 1986; 5: 193–200.

Holm

Ueland

Vollset

. Betaine and folate status as cooperative determinants of plasma homocysteine in humans. Arterioscler Thromb Vasc Biol 2005; 25: 379–385.

Konstantinova

Tell

Vollset

. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr 2008; 138: 914–920.

Wang

Klipfell

Bennett

. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57–63.

Tang

Wang

Levison

. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368: 1575–1584.

Morrow

Cannon

Jesse

. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007; 115: e356–e375.

Dolci

Panteghini

. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta 2006; 369: 179–187.

10.

Muller

Barbato

De Bruyne

. Biomarkers of vulnerable plaque: the missing link with ischemia. Biomark Med 2010; 4: 375–383.

11.

Danne

Mockel

. Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability. Expert Rev Mol Diagn 2010; 10: 159–171.

12.

Bruhl

Hafner

Loffelholz

. Release of choline in the isolated heart, an indicator of ischemic phospholipid degradation and its protection by ischemic preconditioning: no evidence for a role of phospholipase D. Life Sci 2004; 75: 1609–1620.

13.

Imajo

Fujita

Yoneda

. Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: a multi-center validation study. Hepatol Res 2012; 42: 757–766.

14.

Bhatia

Curzen

Calder

. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 2012; 33: 1190–1200.

15.

Svingen

Ueland

Pedersen

. Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris. Arterioscler Thromb Vasc Biol 2013; 33: 2041–2048.

16.

Ying

Rahbar

Hallman

. Associations between dietary intake of choline and betaine and lung cancer risk. PLoS One 2013; 8: e54561–e54561.

17.

Frey

Haupt

Alms

. Increase in fragmented phosphatidylcholine in blood plasma by oxidative stress. Journal of Lipid Research 2000; 41: 1145–1153.

18.

Padmavathi

Reddy

Maturu

. Smoking-induced alterations in platelet membrane fluidity and Na(+)/K(+)-ATPase activity in chronic cigarette smokers. J Atheroscler Thromb 2010; 17: 619–627.

19.

Rival

Riddle

Stein

. Effects of chronic smoking on platelet function. Thromb Res 1987; 45: 75–85.

20.

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol 2012; 19: 585–667.

21.

Ebbing

Bleie

Ueland

. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008; 300: 795–804.

22.

Holm

Ueland

Kvalheim

. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem 2003; 49: 286–294.

23.

Ebbing

Bonaa

Nygard

. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009; 302: 2119–2126.

24.

Koenker

. Quantile regression, New York: Cambridge University Press, 2005.

25.

Body

Griffith

Keevil

. Choline for diagnosis and prognostication of acute coronary syndromes in the Emergency Department. Clin Chim Acta 2009; 404: 89–94.

26.

Danne

Mockel

Lueders

. Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. Am J Cardiol 2003; 91: 1060–1067.

27.

LeLeiko

Vaccari

Sola

. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome. Am J Cardiol 2009; 104: 638–643.

28.

Mockel

Danne

Muller

. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin Chim Acta 2008; 393: 103–109.

29.

Cavusoglu

Chhabra

Jiang

. Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiography. Am J Cardiol 2007; 100: 1739–1743.

30.

Lever

George

Elmslie

. Betaine and secondary events in an acute coronary syndrome cohort. PLoS One 2012; 7: e37883–e37883.

31.

Bidulescu

Chambless

Siega-Riz

. Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovasc Disord 2007; 7: 20–20.

32.

Dalmeijer

Olthof

Verhoef

. Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. Eur J Clin Nutr 2008; 62: 386–394.

33.

Danne

Mockel

. Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability. Expert Rev Mol Diagn 2010; 10: 159–171.

34.

Ketelhuth

Back

. The role of matrix metalloproteinases in atherothrombosis. Curr Atheroscler Rep 2011; 13: 162–169.

35.

Kaplan

Jackson

. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program 2011; 2011: 51–61.

36.

Tsuda

Yoshimura

Hamasaki

. Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the activated factor X-prothrombin system. Blood Coagul Fibrinolysis 2006; 17: 465–469.

37.

Burke

Fitzgerald

. Oxidative stress and smoking-induced vascular injury. Prog Cardiovasc Dis 2003; 46: 79–90.

38.

Watson

Leitinger

Navab

. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 1997; 272: 13597–13607.

39.

Volzke

Schmidt

Baumeister

. Personalized cardiovascular medicine: concepts and methodological considerations. Nat Rev Cardiol 2013; 10: 308–316.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.90 MB

0.01 MB

0.00 MB